Skip to main content

Advertisement

Log in

Endovascular Renal Artery Denervation: Why, When, and How?

  • Review Article/State of the Art
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Krum H, Schlaich MP, Whitbourn R et al (2009) Catheter based renal sympathetic denervation for reistant hypertension: a multicenter safety and proof-of-principle cohort study. Lancet 373:1275–1281

    Article  PubMed  Google Scholar 

  2. Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE, Böhm M (2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The symplicity HTN-2 trial): a randomised controlled trial. Lancet 376(9756):1903–1909

    Article  PubMed  Google Scholar 

  3. Uder M, Schmid A, Titze S, Schmieder R (2011) Renal artery denervation for the treatment of hypertension: opening up new horizons. Cardiovasc Intervent Radiol 34:442–444

    Article  Google Scholar 

  4. Doumas M, Douma S (2010) Renal sympathetic denervation: the jury is still out. Lancet 376(9756):1878–1880

    Article  PubMed  Google Scholar 

  5. DiBona GFS (2002) Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens 11:197–200

    Article  PubMed  Google Scholar 

  6. Schlaich MP, Sobotka PA, Krum H et al (2009) Renal denervation as a therapeutic approach for hypertension. Novel implication for an old concept. Hypertension 54:1195–1201

    Article  PubMed  CAS  Google Scholar 

  7. Mancia G, De Backer G, Dominiczak A et al (2007) Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). J Hypertens 25:1105–1187

    Article  PubMed  CAS  Google Scholar 

  8. O’Brien E, Asmar R, Beilin L et al (2005) European society of hypertension working group on blood pressure monitoring practice. Guidelines of the European society of hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 23:697–701

    Google Scholar 

  9. Calhoun DA, Jones D, Textor S et al (2008) American Heart Association Professional Education Committee resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 117:e510–e526

    Article  PubMed  Google Scholar 

  10. Mancia G, Laurent S, Agabiti-Rosei E et al (2009) Reappraisal of European guidelines on hypertension management: a European society of hypertension Task Force document. Blood Press 18:308–347

    Article  PubMed  CAS  Google Scholar 

  11. Stergiou GS, Myers MG, Reid JL et al (2010) Setting-up a blood pressure and vascular protection clinic: requirements of the European society of hypertension. J Hypertens 28:1780–1781

    Article  PubMed  CAS  Google Scholar 

  12. Streeten DHP, Anderson GH, Wagner S (1990) Effect of age on response to secondary hypertension to specific treatment. Am J Hypertens 3:360–365

    PubMed  CAS  Google Scholar 

  13. Hirsch AT, Haskal ZJ, Hertzer NR et al (2006) ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). Circulation 113:e463–e654

    Article  PubMed  Google Scholar 

  14. Funder JW, Carey RM, Fardella C et al (2008) Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93:3266–3281

    Article  PubMed  CAS  Google Scholar 

  15. Plouin PF, Gimenez-Roqueplo AP (2006) Pheochromocytomas and secreting paragangliomas. Orphanet J Rare Dis 1:49

    Google Scholar 

  16. Chernik DA, Gillings D, Laine H et al (1990) Validity and reliability of the observer’s assessment of alertness/sedation scale: study with intravenous midazolam. J Clin Psychopharmacol 10:244–251

    Article  PubMed  CAS  Google Scholar 

  17. Mancia G, De Backer G, Dominiczak A et al (2007) ESH-ESC task force on the management of arterial hypertension. ESH-ESC practice guidelines for the management of arterial hypertension. J Hypertens 25:1751–1762

    Google Scholar 

  18. Plouin PF, Bobrie G, Chatellier G (2001) How to manage hypertension in clinical practice, and what can be expected from a hypertension clinic. In: Zanchetti A (ed) Hypertension. McGraw-Hill Clinical Medicine Series, McGraw-Hill, New York, pp 241–251

    Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marc Sapoval.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sapoval, M., Azizi, M., Bobrie, G. et al. Endovascular Renal Artery Denervation: Why, When, and How?. Cardiovasc Intervent Radiol 35, 463–471 (2012). https://doi.org/10.1007/s00270-011-0306-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-011-0306-8

Keywords

Navigation